Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.26
Delayed Data
As of Feb 11
 -0.05 / -3.82%
Today’s Change
0.82
Today|||52-Week Range
2.87
-10.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization----2.0K999.57
 
 
 
 
Operating ExpensesGross Income0.000.00-2.0K-999.57
 
 
 
General Expenses619.1K348.6K472.0K394.8K
 
 
 
 
 
Other Operating Expenses0.000.00-0.000.00
 
 
 
Research And Development143.8K38.9K68.0K133.9K
 
 
 
 
 
Total Operating Expenses619.1K348.6K474.0K395.8K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-619.1K-348.6K-474.0K-395.8K
 
 
 
 
 
Other Expenses-102.6K-222.5K53.2K-47.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-721.7K-571.1K-420.8K-442.8K
 
 
 
 
 
Minority Interest-52.2K-1.9K0.000.00
 
 
 
Discontinued Operations-115.4K-426.4K0.000.00
 
 
 
Net Income-784.9K-999.4K-420.8K-442.8K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.6M11.7M13.7M13.7M
 
 
 
 
 
Shares To Calculate EPS Diluted11.6M11.7M13.7M13.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.09-$0.02-$0.04
 
 
 
 
 
EPS Diluted-$0.07-$0.09-$0.04-$0.04